✦ LIBER ✦

Novel therapeutic targets in squamous cell carcinoma of the head and neck

✍ Scribed by Ezra E.W. Cohen

Book ID: 114473616
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 348 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.09.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the immune system: novel thera

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

✍ Thomas K. Hoffmann; Henning Bier; Theresa L. Whiteside 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 344 KB

630: Receptor tyrosine kinases as novel

630: Receptor tyrosine kinases as novel therapeutic targets in head and neck squamous cell carcinoma

✍ Von Mässenhausen, A.; Deng, M.; Vogel, W.; Queisser, A.; Perner, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Vascular Targeting and Therapeutics for

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck

✍ Nabil F. Saba, Zhuo (Georgia) Chen, Professor Dong M. Shin 📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 218 KB

Therapeutic targets in head and neck squ

Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation

✍ Jason D. Howard; Bo Lu; Christine H. Chung 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Molecular Targets in Squamous Cell Carci

Molecular Targets in Squamous Cell Carcinoma of the Head and Neck

✍ Keisuke Shirai; Paul E. O’Brien 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 197 KB

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r